Back
Anheuser-Busch InBev SA/NV Vs. Neurogene Industry Stock Comparison
Buy
58
BUDFF
Anheuser-Busch InBev SA/NV
Last Price:
63.97
Seasonality Move:
1.59%
Sell
40
NGNE
Neurogene
Last Price:
41.53
Seasonality Move:
-0.92%
Buy
58
Anheuser-Busch InBev SA/NV (BUDFF)
is a Buy
Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?
- The current Anheuser-Busch InBev SA/NV [BUDFF] share price is $64.00. The Score for BUDFF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BUDFF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $40.27. The Score for NGNE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BUDFF Stock Price Chart
What is Anheuser-Busch InBev SA/NV's stock price today?
-
The Anheuser-Busch InBev SA/NV share price today is $64.00
The current trend is moderately bullish and BUDFF is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Stock Price Chart
BUDFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 59.71 | Buy |
| Chaikin Money Flow: | -1515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.29 - 63.81) | Buy |
| Bollinger Bands (100): | (59.2 - 63.66) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 57.44 | Buy |
| Chaikin Money Flow: | -29871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.87 - 39.01) | Buy |
| Bollinger Bands (100): | (32.69 - 40.45) | Buy |
BUDFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.28 | Sell |
| 20-day SMA: | 62.54 | Buy |
| 50-day SMA: | 61.21 | Buy |
| 200-day SMA: | 61.67 | Buy |
| 8-day EMA: | 64.04 | Sell |
| 20-day EMA: | 62.92 | Buy |
| 50-day EMA: | 61.79 | Buy |
| 200-day EMA: | 60.9 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.1 | Buy |
| 20-day SMA: | 36.84 | Buy |
| 50-day SMA: | 38.55 | Buy |
| 200-day SMA: | 33.4 | Buy |
| 8-day EMA: | 39.55 | Buy |
| 20-day EMA: | 37.91 | Buy |
| 50-day EMA: | 37.46 | Buy |
| 200-day EMA: | 33.1 | Buy |
Anheuser-Busch InBev SA/NV Earnings Growth & BUDFF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Anheuser-Busch InBev SA/NV Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||